(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the Euronext session.

The three biggest winners today are NORTHERN DRILLING, METABOLIC EXPLORER, and MYHOTELMATCH.

Financial Asset	Price	Change	Updated (EST)
NORTHERN DRILLING (NODL.OL)	1.62	357.63%	2023-11-01 12:41:33
METABOLIC EXPLORER (METEX.PA)	0.72	22.03%	2023-11-01 13:20:20
MYHOTELMATCH (MHM.PA)	1.04	11.97%	2023-11-01 13:20:28
FERMENTALG (FALG.PA)	0.31	11.27%	2023-11-01 13:03:20
MAAT PHARMA (MAAT.PA)	8.86	10.75%	2023-11-01 13:05:52
GYLDENDAL (GYL.OL)	550.00	10%	2023-11-01 12:40:20
ATLANTIC SAPPHIRE (ASA.OL)	1.39	9.42%	2023-11-01 12:24:35
ADUX (ADUX.PA)	1.25	9.17%	2023-11-01 12:44:54
MEDISTIM (MEDI.OL)	210.00	8.53%	2023-11-01 12:41:05
AVANCE GAS HOLDING (AGAS.OL)	161.00	8.34%	2023-11-01 12:24:43

The three biggest losers today are HAVILA SHIPPING, LATECOERE, and BIOSENIC.

Financial Asset	Price	Change	Updated (EST)
HAVILA SHIPPING (HAVI.OL)	6.26	-16.53%	2023-11-01 12:40:24
LATECOERE (LAT.PA)	0.36	-13.06%	2023-11-01 13:05:28
BIOSENIC (BIOS.BR)	0.04	-8.57%	2023-11-01 12:05:05
SERGEFERRARI GROUP (SEFER.PA)	5.84	-8.46%	2023-11-01 13:22:31
ORPEA (ORP.PA)	0.88	-7.85%	2023-11-01 13:21:00
TECHSTEP (TECH.OL)	7.90	-7.55%	2023-11-01 12:43:45
BERGENBIO (BGBIO.OL)	0.20	-6.79%	2023-11-01 12:24:51
NORDIC SEMICONDUC (NOD.OL)	84.14	-6.68%	2023-11-01 12:41:28
CNOVA (CNV.PA)	1.40	-6.67%	2023-11-01 13:01:17
ALTAREIT (AREIT.PA)	420.00	-6.25%	2023-11-01 12:45:21

Winners today

1. NORTHERN DRILLING (NODL.OL)

357.63% Price Change

Northern Drilling Ltd. operates as an offshore drilling contractor to the oil and gas industry. The company primarily engages in acquiring and operating offshore drilling assets, as well as involved in drilling in ultra-deep water environments. Northern Drilling Ltd. was incorporated in 2017 and is based in Hamilton, Bermuda.

Oslo Børs Benchmark Index_GI ended the session with NORTHERN DRILLING jumping 357.63% to €1.62 on Wednesday, after five consecutive sessions in a row of losses. Oslo Børs Benchmark Index_GI jumped 0.01% to €1,281.17, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, NORTHERN DRILLING has a trailing twelve months EPS of kr-6.26.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.22%.

Yearly Top and Bottom Value

NORTHERN DRILLING’s stock is valued at kr1.62 at 21:40 EST, way under its 52-week high of kr34.90 and way above its 52-week low of kr0.31.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORTHERN DRILLING’s stock is considered to be overbought (>=80).

More news about NORTHERN DRILLING.

2. METABOLIC EXPLORER (METEX.PA)

22.03% Price Change

METabolic EXplorer S.A., a biological chemistry company, engages in the development and industrialization of industrial fermentation processes as alternatives to petrochemical processes worldwide. The company also offers propanediol, butyric acid, butyric acid, glycolic acid, amino acid, and L-Valine. Its products are used in the formulation of cosmetics, textiles, polymer, animal nutrition, and health products or as intermediates for the synthesis of biomaterials. The company was incorporated in 1999 and is based in Saint-Beauzire, France.

CAC 40 ended the session with METABOLIC EXPLORER jumping 22.03% to €0.72 on Wednesday while CAC 40 rose 0.68% to €6,932.63.

Earnings Per Share

As for profitability, METABOLIC EXPLORER has a trailing twelve months EPS of €-0.98.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -42.82%.

Yearly Top and Bottom Value

METABOLIC EXPLORER’s stock is valued at €0.72 at 21:40 EST, way under its 52-week high of €1.95 and way above its 52-week low of €0.22.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jan 1, 1970, the estimated forward annual dividend yield is 0.04%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 46.2%, now sitting on 168.16M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, METABOLIC EXPLORER’s stock is considered to be oversold (<=20).

More news about METABOLIC EXPLORER.

3. MYHOTELMATCH (MHM.PA)

11.97% Price Change

MyHotelMatch S.A. engages in the development and exploitation of an online hotel reservation platform based on Artificial Intelligence (AI). It operates as an online travel agency based on the principle of online dating. The company, through its platform, connect a traveler and hotels with online hotel services whose profiles match. The company is based in Biot, France.

CAC 40 ended the session with MYHOTELMATCH jumping 11.97% to €1.04 on Wednesday while CAC 40 jumped 0.68% to €6,932.63.

Earnings Per Share

As for profitability, MYHOTELMATCH has a trailing twelve months EPS of €-1.48.

Volatility

MYHOTELMATCH’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.57%, a negative 1.62%, and a positive 4.23%.

MYHOTELMATCH’s highest amplitude of average volatility was 2.79% (last week), 5.97% (last month), and 4.23% (last quarter).

Yearly Top and Bottom Value

MYHOTELMATCH’s stock is valued at €1.04 at 21:40 EST, way below its 52-week high of €3.88 and way above its 52-week low of €0.81.

More news about MYHOTELMATCH.

4. FERMENTALG (FALG.PA)

11.27% Price Change

Fermentalg SA develops, produces, and sells active ingredients extracted from microalgae for the food, health, nutrition, and environment sectors in France and internationally. It offers DHA ORIGINS, a plant-based DHA oil; aquafeeds and pet foods; BLUE ORIGIN, a natural color; and environmental and clean air solutions that captures CO2 in industries. The company was incorporated in 2009 and is headquartered in Libourne, France.

CAC 40 ended the session with FERMENTALG rising 11.27% to €0.31 on Wednesday while CAC 40 jumped 0.68% to €6,932.63.

Earnings Per Share

As for profitability, FERMENTALG has a trailing twelve months EPS of €-0.24.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.52%.

Moving Average

FERMENTALG’s worth is way under its 50-day moving average of €0.50 and way below its 200-day moving average of €0.90.

Volume

Today’s last reported volume for FERMENTALG is 3737540 which is 4278% above its average volume of 85371.

More news about FERMENTALG.

5. MAAT PHARMA (MAAT.PA)

10.75% Price Change

MaaT Pharma SA, a clinical stage company, engages in the research and development of microbiome biotherapies for the treatment of solid cancer tumors. Its products pipeline includes MaaT013 that has completed phase 2 clinical trials for the treatment of acute graft versus host diseases, as well as in preclinical trials to treat melanoma; MaaT033, which is in phase 1b clinical trials for the improvement of survival in patients with acute myeloid leukemia or other liquid tumors receiving allogeneic hematopoietic stem cell transplantation; and MaaT03X for the treatment of solid tumors. The company was incorporated in 2014 and is headquartered in Lyon, France.

CAC 40 ended the session with MAAT PHARMA rising 10.75% to €8.86 on Wednesday while CAC 40 rose 0.68% to €6,932.63.

Earnings Per Share

As for profitability, MAAT PHARMA has a trailing twelve months EPS of €-1.4.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -46.11%.

More news about MAAT PHARMA.

6. GYLDENDAL (GYL.OL)

10% Price Change

Gyldendal ASA, through its subsidiaries, publishes and sells books in Norway. The company also publishes and produces content, including learning materials for kindergarten, primary school, upper secondary school, students, and professional market; and sells audiobooks and other goods, as well as provides streaming services. It operates bookstores and an online bookstore. The company was founded in 1925 and is headquartered in Oslo, Norway. Gyldendal ASA operates as a subsidiary of Erik Must AS.

Oslo Børs Benchmark Index_GI ended the session with GYLDENDAL rising 10% to €550.00 on Wednesday, after four successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.01% to €1,281.17, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, GYLDENDAL has a trailing twelve months EPS of kr5.4.

PE Ratio

GYLDENDAL has a trailing twelve months price to earnings ratio of 101.85. Meaning, the purchaser of the share is investing kr101.85 for every norwegian krone of annual earnings.

More news about GYLDENDAL.

7. ATLANTIC SAPPHIRE (ASA.OL)

9.42% Price Change

Atlantic Sapphire ASA, together with its subsidiaries, engages in the land-based salmon farming business. It operates through two segments, Fish Farming (Denmark); and Fish Farming (US). The company is involved in the production and sale of salmon. It operates in the United States, Denmark, and internationally. The company was founded in 2010 and is headquartered in Vikebukt, Norway.

Oslo Børs Benchmark Index_GI ended the session with ATLANTIC SAPPHIRE rising 9.42% to €1.39 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.01% to €1,281.17.

Earnings Per Share

As for profitability, ATLANTIC SAPPHIRE has a trailing twelve months EPS of kr-5.43.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -24.26%.

Volatility

ATLANTIC SAPPHIRE’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.51%, a negative 0.95%, and a positive 4.73%.

ATLANTIC SAPPHIRE’s highest amplitude of average volatility was 4.86% (last week), 3.66% (last month), and 4.73% (last quarter).

Moving Average

ATLANTIC SAPPHIRE’s value is way below its 50-day moving average of kr6.29 and way below its 200-day moving average of kr6.74.

More news about ATLANTIC SAPPHIRE.

8. ADUX (ADUX.PA)

9.17% Price Change

AdUX SA provides advertising services in France, Belgium, Italy, Spain, Germany, the Netherlands, and internationally. It provides non-intrusive advertising, in-content advertising, brand content, and geomarketing services. The company was founded in 1996 and is headquartered in Paris, France.

CAC 40 ended the session with ADUX rising 9.17% to €1.25 on Wednesday while CAC 40 rose 0.68% to €6,932.63.

Earnings Per Share

As for profitability, ADUX has a trailing twelve months EPS of €0.72.

PE Ratio

ADUX has a trailing twelve months price to earnings ratio of 1.74. Meaning, the purchaser of the share is investing €1.74 for every euro of annual earnings.

Revenue Growth

Year-on-year quarterly revenue growth declined by 14.4%, now sitting on 23.64M for the twelve trailing months.

Volatility

ADUX’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.01%, a negative 0.01%, and a positive 2.76%.

ADUX’s highest amplitude of average volatility was 2.09% (last week), 3.31% (last month), and 2.76% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ADUX’s stock is considered to be oversold (<=20).

More news about ADUX.

9. MEDISTIM (MEDI.OL)

8.53% Price Change

Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with MEDISTIM jumping 8.53% to €210.00 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.01% to €1,281.17.

Earnings Per Share

As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.4.

PE Ratio

MEDISTIM has a trailing twelve months price to earnings ratio of 32.81. Meaning, the purchaser of the share is investing kr32.81 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.9%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 11.9% and a drop 6.2% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

MEDISTIM’s EBITDA is 102.05.

Moving Average

MEDISTIM’s worth is below its 50-day moving average of kr212.52 and way under its 200-day moving average of kr244.68.

More news about MEDISTIM.

10. AVANCE GAS HOLDING (AGAS.OL)

8.34% Price Change

Avance Gas Holding Ltd, together with its subsidiaries, engages in the transportation of liquefied petroleum gas (LPG). The company transports LPG from the Persian Gulf and the United States Gulf/the United States East Coast to destinations in Europe, South America, India, and Asia. As of December 31, 2022, it owned and operated through a fleet of twelve very large gas carriers and four dual-fuel LPG newbuildings. The company was founded in 2007 and is based in Hamilton, Bermuda. Avance Gas Holding Ltd operates as a subsidiary of Hemen Holding Ltd.

Oslo Børs Benchmark Index_GI ended the session with AVANCE GAS HOLDING rising 8.34% to €161.00 on Wednesday, after five successive sessions in a row of gains. Oslo Børs Benchmark Index_GI jumped 0.01% to €1,281.17, after three consecutive sessions in a row of gains, on what was a somewhat positive trend exchanging session today.

Earnings Per Share

As for profitability, AVANCE GAS HOLDING has a trailing twelve months EPS of kr17.12.

PE Ratio

AVANCE GAS HOLDING has a trailing twelve months price to earnings ratio of 9.4. Meaning, the purchaser of the share is investing kr9.4 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.24%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 15.8%, now sitting on 265.06M for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jun 7, 2023, the estimated forward annual dividend rate is 21.31 and the estimated forward annual dividend yield is 22.06%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AVANCE GAS HOLDING’s stock is considered to be oversold (<=20).

More news about AVANCE GAS HOLDING.

Losers Today

1. HAVILA SHIPPING (HAVI.OL)

-16.53% Price Change

Havila Shipping ASA, together with its subsidiaries, engages in the shipping business. It manages and operates offshore service vessels primarily in Norway, the United Kingdom, Denmark, Belgium, the Netherlands, Iceland, Tunisia, the Marshall Islands, and the United States. The company operates a fleet of 17 vessels, including 2 anchor handling vessels, 11 platform supply vessels, 1 rescue recovery vessel, and 3 subsea vessels. Its anchor handling tug and supply vessels are used for moving rigs and putting out anchors, as well as for supply services; platform supply vessels are used to carry goods, water, drilling mud, chemicals, etc. to and from the offshore installations; subsea vessels are used for under water construction work, as well as for support for under water operations; and rescue recovery vessels are used to offer security services, such as oil spill preparedness, fire protection, rescue operation, and recovery at oil installations. The company was founded in 2003 and is headquartered in Fosnavåg, Norway. Havila Shipping ASA is a subsidiary of Havila Holding AS.

Oslo Børs Benchmark Index_GI ended the session with HAVILA SHIPPING falling 16.53% to €6.26 on Wednesday, after five sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.01% to €1,281.17, after three successive sessions in a row of gains, on what was a somewhat bullish trend trading session today.

Earnings Per Share

As for profitability, HAVILA SHIPPING has a trailing twelve months EPS of kr-4.57.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -59.03%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

HAVILA SHIPPING’s EBITDA is 44.19.

More news about HAVILA SHIPPING.

2. LATECOERE (LAT.PA)

-13.06% Price Change

Latécoère S.A. designs, manufactures, assembles, and installs aerostructures and interconnection systems in Europe, the United States, Africa, Asia, and internationally. The company operates through Aerostructures and Interconnection systems segments. It also supplies doors, fuselage, wings, empennage, and connecting rods, as well as manufactures wing sub-assemblies and fuselage components, such as sections, tail cones, front fairings, and watertight bulkheads. In addition, the company offers interconnection systems components comprising of avionics racks, test benches, EWIS and space harnesses; cameras, screens, data transmission solutions; and other electronics. The company was founded in 1917 and is headquartered in Toulouse, France. Latécoère S.A. is a subsidiary of SCP SKN HOLDING I SAS.

CAC 40 ended the session with LATECOERE dropping 13.06% to €0.36 on Wednesday, following the last session’s downward trend. CAC 40 rose 0.68% to €6,932.63, after two consecutive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, LATECOERE has a trailing twelve months EPS of €-8.3.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -311.52%.

More news about LATECOERE.

3. BIOSENIC (BIOS.BR)

-8.57% Price Change

BioSenic S.A., a biotech company, focuses on developing clinical assets. Its technologies include cutting-edge allogeneic cell and gene therapy platform with differentiated bone marrow sourced mesenchymal stromal cells, which can be stored at the point of use in the hospital; and Arsenic TriOxide platform for use in immuno-oncology to treat graft-versus-host disease, systemic lupus erythematosus, and systemic sclerosis. The company's investigational medicinal product is ALLOB, which is in a Phase IIb clinical trial in patients with difficult tibial fractures' and ArsciCor, which is in Phase III in GvHD is being prepared with an oral treatment. BioSenic S.A. is based in Mont-Saint-Guibert, Belgium.

BEL 20 ended the session with BIOSENIC sliding 8.57% to €0.04 on Wednesday while BEL 20 rose 0.6% to €3,377.06.

Earnings Per Share

As for profitability, BIOSENIC has a trailing twelve months EPS of €7.53.

PE Ratio

BIOSENIC has a trailing twelve months price to earnings ratio of 0.01. Meaning, the purchaser of the share is investing €0.01 for every euro of annual earnings.

Volatility

BIOSENIC’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.54%, a negative 4.14%, and a positive 8.44%.

BIOSENIC’s highest amplitude of average volatility was 4.08% (last week), 6.39% (last month), and 8.44% (last quarter).

Volume

Today’s last reported volume for BIOSENIC is 410241 which is 66.22% below its average volume of 1214620.

More news about BIOSENIC.

4. SERGEFERRARI GROUP (SEFER.PA)

-8.46% Price Change

SergeFerrari Group SA designs, develops, manufactures, and markets composite materials for lightweight architectural and outdoor applications in France and internationally. It provides its products for solar protection, tensile architecture, modular structures, and furniture/marine markets. The company offers solutions for indoor and outdoor blind, and terrace blind and awning; tensile roof and shading structure; indoor and outdoor acoustic treatment; bioclimatic façade, including building construction and renovation; and waterproof breathable membrane applications. It also provides products and solutions for modular structure, visual communication for printed advertisement, protection, environment, and yachting applications. In addition, the company offers outdoor sling seats and membranes for garden furniture; and upholstery for indoor and outdoor furniture. The company was founded in 1973 and is headquartered in Saint-Jean-de-Soudain, France.

CAC 40 ended the session with SERGEFERRARI GROUP dropping 8.46% to €5.84 on Wednesday while CAC 40 jumped 0.68% to €6,932.63.

Earnings Per Share

As for profitability, SERGEFERRARI GROUP has a trailing twelve months EPS of €0.88.

PE Ratio

SERGEFERRARI GROUP has a trailing twelve months price to earnings ratio of 6.64. Meaning, the purchaser of the share is investing €6.64 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.9%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 3.2%, now sitting on 344.2M for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Apr 26, 2023, the estimated forward annual dividend rate is 0.4 and the estimated forward annual dividend yield is 7.6%.

More news about SERGEFERRARI GROUP.

5. ORPEA (ORP.PA)

-7.85% Price Change

ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logistical and residential services, including accommodation, meals, and laundry and room cleaning, as well as various daily event, entertainment, and therapeutic workshop services. The company's post-acute and rehabilitation hospitals offer services for geriatrics, musculoskeletal, nervous system, cardiovascular, hematology, and oncology conditions, as well as patients in a persistent vegetative state or in a minimally conscious state. Its psychiatric hospitals provide services for the patients with mood disorders, anxiety disorders, obsessive-compulsive disorders, addictions, eating disorders, sleep disorders, personality disorders, ageing-related psychiatric disorders, psychosis, over exhaustion or burn-out, chronic fatigue syndrome, fibromyalgia, psychosomatic conditions, and post-traumatic stress disorder conditions, as well as geriatric, child, young adult, parent-child, and public/private patients psychiatry services. In addition, the company offers home care services, including housekeeping services, such as cleaning, meals, ironing, gardening, and household errands; daily life assistance services comprising day or night supervision, assistance with hygiene tasks, and meal-time assistance; and movement assistance services. The company operates in France, Belgium, Spain, Italy, Ireland, Switzerland, Austria, Germany, the Czech Republic, Poland, the Netherlands, Luxembourg, Portugal, Brazil, Russia, Slovenia, Uruguay, Colombia, Mexico, Chile, Latvia, Croatia, and China. ORPEA SA was founded in 1989 and is headquartered in Puteaux, France.

CAC 40 ended the session with ORPEA dropping 7.85% to €0.88 on Wednesday, after two consecutive sessions in a row of losses. CAC 40 rose 0.68% to €6,932.63, after two sequential sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, ORPEA has a trailing twelve months EPS of €-63.9.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -445.48%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ORPEA’s stock is considered to be overbought (>=80).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Jul 9, 2021, the estimated forward annual dividend rate is 0.9 and the estimated forward annual dividend yield is 3.63%.

Moving Average

ORPEA’s worth is way under its 50-day moving average of €1.43 and way under its 200-day moving average of €2.36.

More news about ORPEA.

6. TECHSTEP (TECH.OL)

-7.55% Price Change

Techstep ASA operates as a mobile technology enabler in Norway, Sweden, Denmark, and Poland. It offers mobile hardware, service, support, and mobility consultancy services; software as a service, as well as mobile expense management modules; and financing and remarketing services. The company also provides enterprise mobility management services, including mobile security, system design, implementation, and mobile device management. In addition, it develops and provides enterprise mobility software and solutions for the customers in the transportation, logistics, and public safety sectors, as well as offers mobile device lifecycle management solutions. The company was founded in 2016 and is headquartered in Oslo, Norway.

Oslo Børs Benchmark Index_GI ended the session with TECHSTEP sliding 7.55% to €7.90 on Wednesday, after four successive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.01% to €1,281.17, after three successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, TECHSTEP has a trailing twelve months EPS of kr-2.52.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -15.38%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 8.1%, now sitting on 1.24B for the twelve trailing months.

Volatility

TECHSTEP’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.75%, a negative 0.74%, and a positive 2.66%.

TECHSTEP’s highest amplitude of average volatility was 0.75% (last week), 3.90% (last month), and 2.66% (last quarter).

More news about TECHSTEP.

7. BERGENBIO (BGBIO.OL)

-6.79% Price Change

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of novel medicines to treat immune-evasive, drug resistant, and metastatic cancers; and respiratory diseases. It develops bemcentinib, an oral once-a-day inhibitor of AXL receptor tyrosine kinase, which is in Phase 1b/2a clinical trial to treat non-small cell lung cancer, and Phase 2 clinical trial to treat acute myeloid leukemia and COVID-19. Bemcentinib is also being studied for glioblastoma, 2L lung cancer, melanoma, pancreatic cancer, and mesothelioma. In addition, the company is developing tilvestamab, an anti-AXL function-blocking monoclonal antibody that is in Phase 1b clinical trial for the treatment of ovarian cancer; and mipasetamab uzoptirine, which is in Phase 1 clinical trial for the treatment of solid tumors. It has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

Oslo Børs Benchmark Index_GI ended the session with BERGENBIO sliding 6.79% to €0.20 on Wednesday, after two consecutive sessions in a row of gains. Oslo Børs Benchmark Index_GI rose 0.01% to €1,281.17, after three successive sessions in a row of gains, on what was a somewhat positive trend trading session today.

Earnings Per Share

As for profitability, BERGENBIO has a trailing twelve months EPS of kr-1.65.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -179.58%.

Volatility

BERGENBIO’s last week, last month’s, and last quarter’s current intraday variation average was 12.37%, 3.54%, and 6.40%.

BERGENBIO’s highest amplitude of average volatility was 13.69% (last week), 10.32% (last month), and 6.40% (last quarter).

More news about BERGENBIO.

8. NORDIC SEMICONDUC (NOD.OL)

-6.68% Price Change

Nordic Semiconductor ASA, a fabless semiconductor company, designs, sells, and delivers integrated circuits (ICs) and related products and services for use in short- and long- range wireless applications in Europe, the Americas, and the Asia/Pacific. The company offers bluetooth and multiprotocol Systems-on-Chip (SoCs) that provides short-range connectivity; and Systems-in-Package (SiPs), which offers connectivity on long-range LTE-M and NB-IoT cellular networks. It also provides nRF9160 SiP low power cellular IoT device, nRF Cloud solution, nRF Connect software development kit, and third-party cellular modules; DECT NR+, a non-cellular radio standard; nRF7002 Wi-Fi companion ICs; and nRF52840 and nRF5340 multiprotocol SoCs. In addition, the company offers Bluetooth mesh; Bluetooth direction finding solution; Bluetooth Low Energy SoCs; Bluetooth LE audio products; Matter, a Connected Home over IP solution; Thread, an IP-based wireless networking protocol solution; Zigbee products; ANT solutions, including wireless multiprotocol SoCs supporting the ANT wireless protocol; pre-certified development modules and modems; and range extenders. Further, it provides built-in power management on SoCs and dedicated power management ICs comprising nPM1100 PMIC, nPM1300 PMIC, nPM6001 PMIC, nPM1100 EK, and Power Profiler Kit II; Device-to-nRF Cloud and Cloud-to-nRF Cloud solutions; and application specific integrated circuits and related consulting services. The company's products are used in various applications, such as automotive, beacon, computer peripherals, connected health, connected home, education, industrial automation, LED lighting, logistics and transport, retail and payment, sports and fitness, toys and gaming, virtual reality and augmented reality products, and wearables. Nordic Semiconductor ASA was founded in 1983 and is headquartered in Trondheim, Norway.

Oslo Børs Benchmark Index_GI ended the session with NORDIC SEMICONDUC sliding 6.68% to €84.14 on Wednesday while Oslo Børs Benchmark Index_GI rose 0.01% to €1,281.17.

Earnings Per Share

As for profitability, NORDIC SEMICONDUC has a trailing twelve months EPS of kr2.93.

PE Ratio

NORDIC SEMICONDUC has a trailing twelve months price to earnings ratio of 28.72. Meaning, the purchaser of the share is investing kr28.72 for every norwegian krone of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.88%.

Yearly Top and Bottom Value

NORDIC SEMICONDUC’s stock is valued at kr84.14 at 21:40 EST, below its 52-week low of kr86.32.

Volatility

NORDIC SEMICONDUC’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.29%, a negative 1.12%, and a positive 2.06%.

NORDIC SEMICONDUC’s highest amplitude of average volatility was 0.56% (last week), 2.38% (last month), and 2.06% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, NORDIC SEMICONDUC’s stock is considered to be oversold (<=20).

More news about NORDIC SEMICONDUC.

9. CNOVA (CNV.PA)

-6.67% Price Change

Cnova N.V. operates as an e-commerce company in France and Western Europe. The company offers home appliances, consumer electronics, computers, home furnishings, and leisure and personal goods through its cdiscount.com website. It also operates Cdiscount Voyages, a travel platform; Cdiscount Mobile for cell phone plans; Cdiscount Advertising, a digital marketing solution; Octopia for turnkey marketplace solutions to retailers and e-merchants; and C-Logistics for transportation and logistics services. The company was founded in 1998 and is headquartered in Amsterdam, the Netherlands. Cnova N.V. is a subsidiary of Casino, Guichard-Perrachon S.A.

CAC 40 ended the session with CNOVA falling 6.67% to €1.40 on Wednesday, after five successive sessions in a row of losses. CAC 40 rose 0.68% to €6,932.63, after two successive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

Earnings Per Share

As for profitability, CNOVA has a trailing twelve months EPS of €-0.35.

Revenue Growth

Year-on-year quarterly revenue growth declined by 29.9%, now sitting on 1.44B for the twelve trailing months.

Moving Average

CNOVA’s value is way under its 50-day moving average of €2.51 and way below its 200-day moving average of €3.22.

More news about CNOVA.

10. ALTAREIT (AREIT.PA)

-6.25% Price Change

Altareit SCA operates as a real estate development company in France. The company develops serviced residences, mixed-use urban projects, and business properties. Altareit SCA was incorporated in 1955 and is headquartered in Paris, France. Altareit SCA is a subsidiary of Altarea SCA.

CAC 40 ended the session with ALTAREIT falling 6.25% to €420.00 on Wednesday, after five successive sessions in a row of losses. CAC 40 rose 0.68% to €6,932.63, after two consecutive sessions in a row of gains, on what was a somewhat up trend exchanging session today.

Earnings Per Share

As for profitability, ALTAREIT has a trailing twelve months EPS of €15.99.

PE Ratio

ALTAREIT has a trailing twelve months price to earnings ratio of 26.27. Meaning, the purchaser of the share is investing €26.27 for every euro of annual earnings.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, ALTAREIT’s stock is considered to be overbought (>=80).

More news about ALTAREIT.

Stay up to date with our winners and losers daily report